See All Slides - tctmd.com

Slides

Presentation

Safety and Efficacy of Second-Generation Everolimus-Eluting Xience V vs. Zotarolimus-Eluting Resolute Stents in Real-World Practice

Presenter: K. W. Park

December 25, 2012

Presentation

Prospective Randomized Trial of Thrombectomy vs. No Thrombectomy in Patients with STEMI and Thrombus-Rich Lesions

Presenter: Marco De Carlo

December 20, 2012

Presentation

Renal Sympathetic Denervation for Treatment of Drug-resistant Hypertension

Presenter: Murray Esler

December 19, 2012

Presentation

Intraprocedural Stent Thrombosis: A New Risk Factor for Adverse Outcomes in Pts Undergoing PCI for ACS

Presenter: Sorin J. Brener

December 19, 2012

Presentation

The Prevalence and Outcomes of Transradial PCI for STEMI: NCDR CathPCI Registry, 2007-2011

Presenter: D.V. Baklanov

December 18, 2012

Presentation

Safety and Efficacy of High- vs. Low-Dose Aspirin After Primary PCI in STEMI

Presenter: J. Yu

December 17, 2012

Presentation

Association of Clopidogrel Pretreatment with Mortality, CV Events, and Major Bleeding After PCI

Presenter: A. Bellemain-Appaix

December 17, 2012

Presentation

Self-Expanding vs. Balloon-Expandable Stents in AMI: APPOSITION II

Presenter: R.J. van Geuns

December 16, 2012

Presentation

CYP2C19-2 and 17 Alleles Have Significant Impact on Platelet Response and Bleeding Risk in Patients Treated with Prasugrel After ACS

Presenter: Thomas Cuisset

December 16, 2012

Presentation

Quality and Impact of Risk Factor Control in Patients with Stable Claudication Presenting for Peripheral Vascular Interventions

Presenter: A. K. Ardati

December 13, 2012

Advertisement

Slides

Safety and Efficacy of Second-Generation Everolimus-Eluting Xience V vs. Zotarolimus-Eluting Resolute Stents in Real-World Practice

Prospective Randomized Trial of Thrombectomy vs. No Thrombectomy in Patients with STEMI and Thrombus-Rich Lesions

Renal Sympathetic Denervation for Treatment of Drug-resistant Hypertension

Intraprocedural Stent Thrombosis: A New Risk Factor for Adverse Outcomes in Pts Undergoing PCI for ACS

The Prevalence and Outcomes of Transradial PCI for STEMI: NCDR CathPCI Registry, 2007-2011

Safety and Efficacy of High- vs. Low-Dose Aspirin After Primary PCI in STEMI

Association of Clopidogrel Pretreatment with Mortality, CV Events, and Major Bleeding After PCI

Self-Expanding vs. Balloon-Expandable Stents in AMI: APPOSITION II

CYP2C19-2 and 17 Alleles Have Significant Impact on Platelet Response and Bleeding Risk in Patients Treated with Prasugrel After ACS

Quality and Impact of Risk Factor Control in Patients with Stable Claudication Presenting for Peripheral Vascular Interventions

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content